Avoro Capital Advisors’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.33M | Hold |
2,849,402
| – | – | 0.09% | 30 |
|
|
2025
Q1 | $5.07M | Hold |
2,849,402
| – | – | 0.08% | 33 |
|
|
2024
Q4 | $8.99M | Hold |
2,849,402
| – | – | 0.13% | 39 |
|
|
2024
Q3 | $5.87M | Hold |
2,849,402
| – | – | 0.09% | 34 |
|
|
2024
Q2 | $4.16M | Hold |
2,849,402
| – | – | 0.06% | 38 |
|
|
2024
Q1 | $6.67M | Hold |
2,849,402
| – | – | 0.08% | 45 |
|
|
2023
Q4 | $5.76M | Hold |
2,849,402
| – | – | 0.08% | 42 |
|
|
2023
Q3 | $13.8M | Hold |
2,849,402
| – | – | 0.22% | 36 |
|
|
2023
Q2 | $19.5M | Hold |
2,849,402
| – | – | 0.26% | 33 |
|
|
2023
Q1 | $20.6M | Hold |
2,849,402
| – | – | 0.31% | 30 |
|
|
2022
Q4 | $36.6M | Hold |
2,849,402
| – | – | 0.55% | 27 |
|
|
2022
Q3 | $40.3M | Buy |
2,849,402
+1,020,000
| +56% | +$14.4M | 0.74% | 22 |
|
|
2022
Q2 | $22.5M | Hold |
1,829,402
| – | – | 0.45% | 29 |
|
|
2022
Q1 | $31M | Hold |
1,829,402
| – | – | 0.57% | 27 |
|
|
2021
Q4 | $44.2M | Hold |
1,829,402
| – | – | 0.75% | 21 |
|
|
2021
Q3 | $53.7M | Buy |
1,829,402
+1,529,402
| +510% | +$44.9M | 0.84% | 23 |
|
|
2021
Q2 | $7.61M | Buy |
+300,000
| New | +$7.61M | 0.13% | 44 |
|